Ignite Creation Date:
2024-05-06 @ 2:13 PM
Last Modification Date:
2024-10-26 @ 1:26 PM
Study NCT ID:
NCT04243616
Status:
RECRUITING
Last Update Posted:
2024-02-06
First Post:
2020-01-24
Brief Title:
Cemiplimab in High Risk or Locally Advanced Hormone Receptor Positive HER2 Negative or Triple-Negative Breast Cancer
Sponsor:
Medical College of Wisconsin
Organization:
Medical College of Wisconsin
Organization Data
Organization:
Medical College of Wisconsin
Class:
OTHER
Study ID:
PRO00037175
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Medical College of Wisconsin
Lead Sponsor Class:
OTHER
Responsible Party:
Lubna Chaudhary
Responsible Party Title:
Assistant Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Medical College of Wisconsin
Old Name:
None
Old Organization:
None